• Skip to main content
  • Skip to primary sidebar

Gold Coast Health & Knowledge Precinct

Transform with us

  • Home
  • About Us
    • Strategic Plan
    • Partners
      • City of Gold Coast
      • Griffith University
      • Gold Coast Health
      • Economic Development Queensland
      • Gold Coast Private Hospital
      • Cohort
      • Southport Sharks
    • Our people
    • Precinct Office
    • Map
    • Contact Us
  • Do Business
    • Investment Incentives
  • Live & Play
    • Australia’s Gold Coast
    • Residential – Smith Collective
    • Lifestyle – Retail and Recreation
  • Work & Study
  • Projects
    • Projects Overview
    • ADaPT
    • Clinical Entrepreneurship Change Agents Program
    • NeuTex Image-guided Surgery and Robotics Training Centre
  • Research
    • Overview
      • Additive Manufacturing
      • Biotechnologies
    • Research Institutes and Centres
    • Precinct experts
    • Research Equipment & Facilities
    • Clinical Trials
    • Health and medical training and conference hub
  • News
    • Latest News
    • Newsletter
    • Media
    • Video Channel
  • 中文
    • English
    • 中文
You are here: Home / News

News

Filed Under: HEALTH, TECHNOLOGY Tagged With: Gold Coast Private Hospital, Griffith University, orthopaedics, Professor Randy Bindra

New orthopaedic surgery techniques for breaks, tears and pain

Dr Simon Platt, Gold Coast Private Hospital, is just one of the Precinct's innovative orthopaedic surgeons

Orthopaedic treatment continues to advance, utilising robotic surgery, innovative regenerative medicine techniques including 3D printing, and minimally-invasive procedures where possible to reduce risks and hasten healing.

From ‘all inside’ surgery for knee and ankle ligament repairs to alternative hip replacement techniques, surgeons at Gold Coast Private and Gold Coast University hospitals, and research colleagues at Griffith University, innovate to fix the breaks, replace and repair joints, ligaments and tendons and ease pain and arthritis.

Returning from working in the UK, Dr Annabelle Stabler has recently launched the city’s first private paediatric orthopaedic service, and joined her father,  veteran upper limb orthopaedic surgeon Dr David Stabler, who in his 35 years in practice has seen the Gold Coast orthopaedics field grow from 8 or 9 surgeons in the mid-1980’s, to around 70 now.

For the younger Dr Stabler, her work is as much about fixing childhood problems as it is about preventing issues in adulthood.

“With developmental dysplasia of the hip, and neuromuscular hip conditions in particular, screening and early non-operative intervention can make a huge difference for many children,” Dr Stabler says.

Dr Stabler has a particular interest in looking after children with hip problems, including babies with dysplastic hips, older children with Perthes and SUFE and children with neuromuscular conditions such as Cerebral Palsy.

Cutting edge research and surgery

Associate Professor Dr Chris Carty from the Queensland Children's Hospital (left) and Professor David Lloyd, who heads up the Griffith Centre from Biomedical and Rehabilitation Engineering (GCore), discuss personalised paediatric surgeries

It’s been a big team effort to develop award-winning technology incorporating in-silico (digitally-enabled) surgery and implant design, and 3D printed surgical cutting guides for individual paediatric patients – eight surgeries have now been successfully performed at Queensland Children’s hospital, thanks to the cutting-edge collaboration between surgeons and Griffith University researchers, led by Associate Professor Chris Carty. These digitally-enabled surgeries are reducing theatre time and aiming to improve patient outcomes, in what is an Australian-first. Read more

Professor Randy Bindra with prototype testing machine
Professor Randy Bindra

Fellow GCore clinical researcher Professor Randy Bindra continues to innovate, as clinical lead of a ground-breaking project to develop artificial wrist ligament to treat a common sports injury, and his quest for precision medicine extends all the way to the precious fingertips.

“In the past, fingertip injuries would simply be treated with amputation,” Professor Bindra says.

“With the right care, finger injuries including the tip, can be salvaged and restored – without it, these injuries can become a nightmare.”

Stepping forward with minimally invasive techniques

Dr Sonja Schleimer, Gold Coast Private Hospital

Minimally-invasive techniques in bunion surgery are relatively new to Australia, but foot and ankle surgeon Sonja Schleimer has years of experience, after training in Paris under one of its pioneers.

“MIS bunion surgery evolved in Europe over the last 15 years, but it has only been available in Australia for about the last five years or so,” says Dr Schleimer.

“I was very fortunate to spend some time operating with Dr Oliver Laffenetre, who was heavily involved in developing and evolving MIS techniques for forefoot surgery.”

Meanwhile, Dr Simon Platt is one of only a handful of orthopaedic surgeons in Queensland performing an “all-inside” ligament reconstruction to help patients suffering from chronic ankle instability get back into the sporting arena.

The foot and ankle specialist, who recently joined Gold Coast Private, says the less invasive technique, known as the ArthroBrostrom, resulted in fewer wounds, swelling and scaring than the more traditional approach to surgery.

Dr Price Gallie, Gold Coast Private

Dr Price Gallie also employs an ‘all-inside’ technique, in his case, for common knee surgery, with his arthroscopic ACL reconstruction using a shorter graft with a wider diameter that allows an accelerated recovery and may reduce the risk of re-rupture.

He employs a variety of grafts including the patellar tendon, quadriceps tendon and allograft (donor tendon), alongside the traditionally-used hamstring – matching the graft to the patient, rather than the other way around.

“With ACL reconstruction, we aim to restore normal movement and function, which is why I pioneered the introduction of the “all-inside” technique using the TLS® system,” he says.

More recently Dr Gallie has focussed on other graft choices and is currently studying the use of the peroneus longus tendon with very promising outcomes.

“We need to treat each patient on an individual basis rather than doing the same generic operation for everyone.”

For Dr Stephen Sprague, hip surgery is all about the contemporary approach – which is ‘front to back’ from the standard one.

Hip joint replacement surgery is traditionally done via a posterior approach through the back of the hip, but after training in the anterior method eight years ago, Dr Sprague prefers the alternative.

“Having performed both approaches during my career, I have observed that in the short-term people find the anterior approach less painful, while long-term outcomes are very similar,” he says.

“A huge benefit of the anterior approach is the reduced risk of dislocation which means the patient doesn’t have to worry about it in their day-to-day activities and can resume a much more normal lifestyle.”

Gold Coast Private has advanced state-of-the-art robotic technology giving surgeons the option of performing robot-assisted surgery in orthopaedics, ENT and neurology.

Orthopaedic lower limb surgeon Dr Andrew Letchford, offers robotic surgery for hip and knee joint replacement for improved planning and precision.

“Robotic-assisted surgery has only been available in Australia since 2016. We await joint registry confirmation of the full impact of this technology, however, we are definitely seeing improvements in the performance of partial knee replacement surgery,” Dr Letchford says.

“In my hands, I’ve certainly found a much more uniform, reliable outcome for my patients in the post-operative phase. Computer navigation has been around for many years and with the addition of robotic technology we have now developed ways to finely balance a joint replacement in real time.”

 

November 30, 2020 By Kathy Kruger

Filed Under: HEALTH, PROJECTS

Gold Coast accelerates as a clinical trial hub during COVID-19 times

Griffith University's Clinical Trials Unit (CTU)

Business at Griffith University’s Clinical Trials Unit (CTU) has not only continued but thrived in the midst of a pandemic, with the site being first globally to recruit patients for a multi-national rheumatology trial and screening the first patient in Australia for another multi-national trial.

The Gold Coast and Queensland have benefited from the state’s current low COVID-risk status, to accelerate capability that had been rapidly building, pre-pandemic.

Australia's largest regional clinical trials location - and growing

A 2019 study, commissioned by the Gold Coast Health and Knowledge Precinct, Regional Development Australia (RDA) Gold Coast and the Queensland Government Department of State Development, Tourism and Innovation, found the Gold Coast was Australia’s largest regional clinical trial location, with 126 trials contributing almost $12 million per annum to the city’s economy, and significant growth anticipated over the coming decade.

Director of the Griffith University Clinical Trial Unit, Professor Evelin Tiralongo, said growth could be even stronger than earlier projections of the local sector being worth $33 million by 2029, with further demand likely to be caused by the pandemic.

“Providing high-quality clinical trial services to global and national sponsors, as well as supporting researcher-led trials, is core business for us, and being able to operate in a COVID-safe way, in an environment with so far low levels of coronavirus in the community in Australia, Queensland, and the Gold Coast in particular, is an advantage,“ Professor Tiralongo said.

Professor Evelin Tiralongo

“After some initial disruptions to active trials, we worked very quickly on setting up a COVID-19 safe plan to enable us to continue providing essential services for existing clinical trials and subsequently take on new business, with great support from the University, our External Advisory Committee and the clinicians and other health professionals we work with.”

With intense focus on multiple COVID-19 trials worldwide, researchers, including Griffith’s Professor Michael Good AO, Principal Research Leader at the Institute for Glycomics and a member of the Australian Government’s National COVID-19 Health and Research Advisory Committee, continue to press the need for vital research and trials into other important conditions to continue, or risk significant health consequences.

Professor Michael Good

Many such important trials are currently being conducted at Griffith’s Clinical Trial Unit in areas such as rheumatology, neurology, endocrinology, renal disease, gastrointestinal disorders and infectious diseases, with the unit looking to expand into dermatology and cardiology.

Dr Claire Williams, the Clinical Trial Unit’s Business and Operations Manager, has welcomed the opportunity to take part in these studies and expand the CTU’s business.

“Despite everyone’s attention being currently focussed on COVID-19, it’s still vitally important that we continue to develop and improve vaccines and treatments for other chronic and serious diseases. As a University Core Research Facility, it is crucial to continue to support Griffith researcher-led trials and take on pharma trials so that we can enhance clinical research and knowledge and offer possible new therapy options to the Gold Coast community,” said Dr Williams.

“We are undertaking trials which focus on outpatients and greatly value the continuous and growing collaboration with clinicians from General Practice, Specialised Private Practice, the Gold Coast Hospital and Health Service and other providers. Being in the same building as the Griffith’s Health Clinics and Menzies Health Institute Queensland makes it easy to collaborate with other Allied Health professionals and researchers.”

Clinicians who would like to collaborate on current and planned trials at Griffith’s CTU should contact CTU management for further information [email protected] and volunteers can register their interest via the CTU’s website here.

October 29, 2020 By Kathy Kruger

Filed Under: BUSINESS, People of the Precinct, Research

People of the Precinct – discovering an ocean of possibilities through data science

Dr Stephanie Chaousis is connecting academia, industry and healthcare to the power of AI and data science

With technology company Datarwe opening its doors to a new DataScience lab within Cohort in the Gold Coast Health and Knowledge Precinct, it can accelerate development of its Precision Medicine Data Platform (PDMP), a world-leading comprehensive acute care medical research platform – providing a major new resource to develop AI enabled diagnostics, treatment protocols and med-tech products in Queensland.

Driving partnerships and engagement, including a major partnership with Griffith University, is former alumnus Dr Stephanie Chaousis, an Ecotoxicology PhD whose own research saw her wading through a sea of data to develop a keen appreciation for the potential of AI and machine learning.

When Stephanie Chaousis undertook her undergraduate marine and molecular science studies at James Cook University, before completing post-graduate honours exploring therapeutic effects of jellyfish venom at the Australian Institute of Tropical Health and Medicine in 2012, the opportunities presented by the next-generation of artificial intelligence (AI) may still have seemed oceans away, for novice researchers like herself.

Only eight years ago the potential of AI and machine learning for researchers, industry and indeed the whole world, was being rapidly developed in university computer science labs, tech companies and major corporations, but the ripple effect on research in other scientific fields was still to be fully felt.

Steph’s jellyfish project called for separating out multiple different molecules to determine which were lethal and which weren’t, in the hunt for those that might prove therapeutic – painstaking laboratory analysis performed without the help of a handy predictive algorithm.

After a short segue at the University of Queensland’s Institute for Molecular Bioscience, probing therapeutic opportunities in Tarantula venom, Steph embarked on a PhD at Griffith University in 2015, in a bid to discover a protein biomarker for exposure to chemical pollution from the cell and blood samples of sea turtles.

By the time she was completing her final thesis to earn her doctorate and play her part in marine conservation, she had some 200,000 data points to work with, and was convinced of the opportunity that AI presents in an increasingly ‘big data’ world.

Steph (right) with research colleagues during her PhD at Griffith University

“When you have too much data it becomes more challenging to derive meaning, so I got really interested in AI and machine learning from that point.”

Having worked in both lab and teaching assistant roles at Griffith throughout her PhD studies, Steph proved her versatility by finding a position as an Environmental Scientist for the City of Gold Coast’s Water and Waste directorate, while simultaneously interning with Griffith’s Institute for Glycomics as a Business Analyst.

She’d previously connected with Datarwe CTO Dr Kelvin Ross at a Cohort event, and kept in touch, so he came knocking when the fast-growing company needed an energetic exponent of Data Science and AI, who could build collaboration with researchers in industry, academia and healthcare.

“It’s really exciting to be working with Datarwe from such an early stage and being a part of the company’s growth. Being in this space has offered up great opportunities such as developing and overseeing the MedTech Program for the new Queensland AI Hub, which is a dual role I’m currently in,” Steph says.

“What’s exciting about AI is that it can provide us with accurate prediction using insights from the medical data we already have access to – so rather than relying on future studies and trials, we can look retrospectively for clues and answers. But in order to extract this meaning, the data needs to be useable, accessible, accurate and secure, which is what we are doing at Datarwe by building the PMDP.”

The Datarwe data science technologies lab at Cohort

Datarwe’s PDMP, which earlier this year received $1.5 million funding from Advance Queensland, works by collecting de-identified patient data from hospital Intensive Care Units’ monitoring devices and clinical notes. The data is securely enriched so it can be used by developers to create tools using AI and ML to develop predictive analytics, which then help health care professionals make timely decisions at the patient’s bedside.

It’s a potentially life-saving platform, especially in the midst of a pandemic, and Steph was eager to inspire innovation, as chair of the inaugural Queensland AI Hub Medical Datathon, held in virtual mode in July.

Staged over two weekends, the event brought together multidisciplinary teams with expertise in data science, ML and AI, with clinicians and medical researchers, as well as the business and student communities, to work with real-world data on new medical applications. The impact has extended well beyond, with many teams continuing to develop their projects to make waves in the world of AI – read more.

“Overall, the last 6 months working at Datarwe and the AI Hub has opened my eyes to the appetite in Queensland, and particularly the Gold Coast, for the kind of advanced technology we are building at Datarwe and supporting through the Hub.

As I have personally experienced, the job opportunities in this space are growing rapidly right here in the GCHKP and Lumina, and I’m glad to be able to support the growth of this important industry for Queensland.”

Connect with Steph

October 29, 2020 By Kathy Kruger

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Interim pages omitted …
  • Page 34
  • Go to Next Page »

Primary Sidebar

Recent Posts

  • Healthtech Summit celebrates a future of personalised medicine, AI and hope
  • From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort
  • A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast
  • Clinician Entrepreneurship Program wraps as a big success
  • 2025 International Women’s Day
  • International Women’s Day event 2025
  • Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research
  • INVEST-FEST accelerates founder funding
  • Student innovation incubator set to launch in 2025
  • World-first clinical trial for treating spinal cord injury

Archives

  • June 2025
  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • May 2024
  • April 2024
  • January 2024
  • December 2023
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018

Subscribe to our newsletter and we’ll update you on all that’s new in our Precinct.

Latest News

Healthtech Summit celebrates a future of personalised medicine, AI and hope image

Healthtech Summit celebrates a future of personalised medicine, AI and hope

Read More >

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort image

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort

Read More >

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast image

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast

Read More >

Clinician Entrepreneurship Program wraps as a big success image

Clinician Entrepreneurship Program wraps as a big success

Read More >

2025 International Women's Day image

2025 International Women's Day

Read More >

International Women's Day event 2025 image

International Women's Day event 2025

Read More >

Before Footer

Search

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration and jobs of the future.

  • Home
  • About Us
  • Precinct Map
  • News
  • Do Business
  • Work & Study
  • Partners
  • Projects
  • Research
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Subscribe
  • Facebook
  • LinkedIn
  • YouTube

© 2025 Gold Coast Health and Knowledge Precinct. All rights reserved.

Designed and Developed by Stead Lane